Introduction

In real-world molecular diagnostics, PCR reactions are frequently challenged by PCR inhibitors rather than template quality itself.

Clinical and environmental samples often contain substances such as whole blood, humic acids, ethanol, guanidine salts, and crude lysates, which can severely inhibit DNA polymerase activity. As a result, researchers commonly face failed amplification, unstable Ct values, missing bands in multiplex PCR, and poor sensitivity at low template concentrations.

These issues highlight a key limitation of conventional Taq DNA polymerases, which typically perform well only under clean and optimized conditions. However, most diagnostic applications—including direct PCR, clinical pathogen detection, environmental monitoring, and multiplex qPCR assays—operate in inhibitor-rich environments.

To address these challenges, a new generation of inhibitor-resistant hot-start Taq polymerase is required.

Hzymes has developed a high-performance hot-start Taq DNA polymerase specifically designed for direct PCR, multiplex PCR, and rapid amplification workflows. The enzyme is antibody-inactivated at room temperature and rapidly activated within 30 seconds at 95°C, ensuring both high specificity and operational convenience.

With strong resistance to PCR inhibitors and excellent amplification efficiency, it is well suited for fast PCR, high-sensitivity detection, and complex sample analysis.

Core Advantages

1. Strong resistance to PCR inhibitors (direct PCR compatible)

ClinAmp Taq polymerase demonstrates excellent tolerance to common PCR inhibitors, including whole blood, ethanol, guanidine hydrochloride, humic acid, and high-salt conditions.

It enables robust amplification in direct PCR workflows using crude samples or nucleic acid release reagents, significantly improving reliability in clinical and environmental testing.

2. Ultra-fast extension for rapid PCR applications

The enzyme supports extremely fast DNA synthesis, achieving 1 kb amplification in just 4 seconds, making it ideal for rapid PCR and high-throughput diagnostic workflows.

This dramatically reduces total PCR runtime and improves laboratory efficiency.

3. High sensitivity for low-copy detection

Even at very low template concentrations, the system maintains stable and specific amplification of target sequences.

This ensures accurate detection in low-copy qPCR assays and high-sensitivity molecular diagnostics, where early target identification is critical.

4. High specificity in multiplex PCR (up to 20-plex)

The polymerase delivers excellent performance in multiplex PCR and multiplex qPCR systems, enabling accurate amplification of up to 20 targets in a single reaction.

All expected amplicons are clearly resolved, supporting reliable multi-target detection in diagnostic panels.

5. Strong dUTP tolerance for UDG anti-contamination systems

The enzyme maintains stable amplification efficiency in dUTP-containing PCR systems, with no significant Ct shift observed.

This ensures full compatibility with UDG-based carryover contamination prevention systems, supporting contamination-free molecular diagnostics without compromising performance.

6. Fully premixed PCR system compatibility (37°C stability)

FS Taq-based systems support fully premixed PCR formulations, enabling simplified workflows for diagnostic kit development.

Stability testing shows that premixed systems incubated at 37°C for 8 days maintain Ct values and fluorescence signals comparable to freshly prepared controls, demonstrating excellent reagent stability for commercial PCR kits.

Application Highlights 

This inhibitor-resistant hot-start Taq polymerase is optimized for:

• Direct PCR from blood and crude samples
• Clinical pathogen detection (respiratory, blood-borne, etc.)
• Environmental PCR with inhibitor-rich matrices
• Multiplex PCR / multiplex qPCR panels
• Rapid PCR and fast diagnostic workflows
• UDG/dUTP contamination-controlled PCR systems
• Fully premixed diagnostic kit development

Performance Evaluation Data

01 Strong resistance to PCR inhibitors

Whole blood, nucleic acid release reagents (ethanol, guanidine hydrochloride), and humic acid were used to simulate inhibitory conditions in clinical and environmental samples, including blood, nasopharyngeal swabs, soil, and plant matrices.

Amplification was performed using ClinAmp Taq polymerase. Compared with competitor products, ClinAmp Taq demonstrated significantly improved tolerance to common PCR inhibitors, making it suitable for direct PCR and crude extract-based workflows across a wide range of complex sample types.

02 Fast extension capability for rapid PCR workflows

Different Taq polymerases were evaluated for amplification of a 2 kb target fragment under extension times of 7 s, 15 s, 30 s, 1 min, and 2 min at 72°C.

Both FS Hot Start Taq and ClinAmp Taq successfully amplified the 2 kb fragment with only 7 seconds of extension time, demonstrating strong suitability for ultra-fast PCR protocols and time-sensitive diagnostic applications.

03 Ultra-high sensitivity for low-copy detection

A plasmid template dilution series ranging from 1 copy to 1×10⁶ copies (7 gradients) was used for qPCR analysis.

Results showed that both FS Hot Start and ClinAmp Taq achieved a limit of detection as low as 1 copy. Amplification efficiency remained within 90–110%, with excellent linearity (R² ≥ 0.99), indicating strong performance in low-abundance target detection.

04 High multiplex capability and specificity

A 20-plex PCR system was constructed to evaluate multiplex amplification performance, and products were analyzed by agarose gel electrophoresis.

All expected amplicons were clearly and specifically detected for both FS Hot Start Taq and ClinAmp Taq, demonstrating reliable performance in high-order multiplex PCR systems (up to 20 targets per reaction).

05 Strong dUTP tolerance for UDG contamination control systems

qPCR assays were performed using reaction systems containing different ratios of dUTP.

Both enzymes showed no significant Ct shift across conditions, indicating excellent compatibility with UDG-based carryover contamination prevention systems and flexible optimization of dTTP/dUTP ratios.

06 Compatible with fully premixed PCR systems

Using a Macro & Micro 48SC instrument, a fully premixed PCR system prepared with Hzymes HMD0221 Taq polymerase was evaluated for stability and performance.

The system was used to detect influenza A (FAM), influenza B (HEX), and human internal control (Cy5). After incubation at 37°C for 8 days (compared with freshly prepared controls), samples containing 1×10⁴ and 5×10² copies/mL were tested.

The total runtime was 27 minutes. No significant differences in Ct values or fluorescence intensity were observed between aged and fresh systems, demonstrating excellent stability and strong potential for fully premixed diagnostic assay development.

Products Ordering